Molecular Discovery Paves Way for New Diabetic Heart Disease Treatments
News Aug 13, 2015
Diabetes affects more than 365 million people worldwide with rates expected to double by 2030. Recent studies show that at least 60% of people with the disease die because of cardiovascular complications.
Why diabetes takes such a toll on heart health has long remained a mystery. Now the Otago researchers have identified harmful molecular changes in the cells of diabetic hearts that begin before cardiovascular symptoms even appear.
Using the type-2 diabetic mouse model, the researchers found that a normal cell process called autophagy is deregulated in diabetic hearts. A marked increase in autophagy then triggers activation of pro-cell death proteins, which leads to progressive loss of cardiac cells. As more cells die, cardiac dysfunction develops and heart failure ensues.
Lead researcher Dr Rajesh Katare says the team sought to confirm their laboratory-based results by collaborating with cardiothoracic surgeons at Dunedin Hospital to collect and study heart tissue samples from coronary bypass patients.
The researchers matched around 35 such diabetic patients to comparable non-diabetic ones. Analysis revealed markedly increased autophagy in the diabetic patients’ heart tissues compared to the non-diabetic ones.
They also identified that diabetes increases autophagy through activation of the protein (Beclin-1), which Dr Katare says presents “an extremely promising target for new treatments of diabetes-related cardiac disease”.
“We found that these molecular alterations begin in the diabetic heart from an early stage of the disease—before any clinically identifiable symptoms—so blocking them could be useful in combating cardiovascular complications in diabetes.”
When the researchers lowered the gene expression of Beclin-1 in rat heart cells exposed to high glucose, excessive autophagy and cell death rates were much reduced, he says.
“Given that the growing diabetes epidemic is set to create major global economic and social costs in coming decades, it is very exciting to have opened up a new research avenue that could greatly decrease the disease’s burden,” Dr Katare says.
You Are What Your Mother EatsNews
While many factors, such as the age of the mother, overall health and genetics ultimately play a role, the correlation between a mother’s nutrition habits and metabolism has been proved to directly impact the growth of her child. And researchers believe they may be one step closer to knowing why.READ MORE
Pigs as Models for Zika Virus ResearchNews
Zika virus is pathogenic to humans and nonhuman primates but does not naturally affect other species, complicating studies on pathogenesis and the evaluation of vaccines and antiviral therapies. Due to the similarities in physiology, anatomy and the immune system between pigs and humans it was evaluated if pigs can be used as human surrogates in Zika virus research.READ MORE
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018